Long-term lamivudine treatment of children with chronic hepatitis B: Durability of therapeutic responses and safety

M. M. Jonas*, N. R. Little, S. D. Gardner, E. M. Alonso, F. Alvarez, J. Areias, I. Badia, G. Cordeiro Ferreira, D. Gremse, B. Haber, D. Kelly, N. Manolaki, J. Mizerski, P. Mohan, J. Molleston, K. Murray, I. Pó, G. Porta, N. Rodriguez-Baez, K. SchwarzE. Sokal, W. Sluzewski, M. Woynarowski

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

45 Scopus citations

Fingerprint

Dive into the research topics of 'Long-term lamivudine treatment of children with chronic hepatitis B: Durability of therapeutic responses and safety'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science